Top Losers

TherapeuticsMD Inc (NYSE: TXMD) shares dropped 12.8 percent to $4.91 following cautious-sounding TX-004HR regulatory update. Peregrine Pharmaceuticals (NASDAQ: PPHM) shares tumbled 12.7 percent to $4.87 as the company reported a wider loss for its fourth quarter on Friday. VirnetX Holding...

Reed's, Inc. (NYSE: REED) shares dipped 29.8 percent to $1.65 as the company reported Warrant Exercise Agreements resulting in a $1.6 million financing. CRH Medical Corp (NYSE: CRHM) shares dropped 21 percent to $4.15. A10 Networks Inc (NYSE: ATEN) shares declined 19.1 percent to $6....

DragonWave, Inc.(USA) (NASDAQ: DRWI) shares dropped 14.7 percent to $0.930. DragonWave reported a Q1 loss of $0.52 per share on revenue of $9 million. XCel Brands Inc (NASDAQ: XELB) shares fell 8.8 percent to $3.10. TESARO Inc (NASDAQ: TSRO) shares dropped 7.7 percent to $127.66. Tesaro...

Ocular Therapeutix Inc (NASDAQ: OCUL) shares tumbled 23.3 percent to $5.83 after the biopharmaceutical company confirmed a major setback for its eye drug Dextenza, a therapy used for the treatment of ocular pain following ophthalmic surgery. Ocular confirmed in a press release after Tuesday...

Yuma Energy, Inc. (NYSE: YUMA) shares declined 30.5 percent to $1.55. VOXX International Corp (NASDAQ: VOXX) shares tumbled 16.7 percent to $7.38 after the company posted a wider-than-expected loss for its first quarter. Zion Oil & Gas, Inc. (NASDAQ: ZN) shares dropped 16.3 percent...

Abercrombie & Fitch Co. (NYSE: ANF) shares tumbled 20.4 percent to $9.68 on news that it had terminated talks for a potential sale. The board announced in a press release that the best conceived way to increase shareholder value is through pursuit of its enduring strategy. LeMaitre...

Cherokee Inc (NASDAQ: CHKE) shares dipped 31 percent to $5.35 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share. ImmunoCellular Therapeutics Ltd (NYSE...

Egalet Corp (NASDAQ: EGLT) shares tumbled 36.3 percent to $1.62. Egalet reported pricing of public offering of common stock and warrants. Tahoe Resources Inc (NYSE: TAHO) shares dipped 30.3 percent to $5.78 following Guatemalan Court suspension of Escobal mining license. BMO Capital...

Diebold Nixdorf Inc (NYSE: DBD) shares tumbled 20.5 percent to $22.27 as the company lowered its FY17 outlook. O'Reilly Automotive Inc (NASDAQ: ORLY) shares dropped 19.4 percent to $177.72 following disappointing Q2 comparable sales report. O'Reilly Q2 same store sales rose 1.7...

Diana Containerships Inc (NASDAQ: DCIX) shares dipped 25.4 percent to $0.280. Diana Containerships disclosed a 1-for-7 reverse stock split. Yield10 Bioscience Inc (NASDAQ: YTEN) shares tumbled 18.8 percent to $4.18. Yield10 Biosciences priced its $2.3 million direct offering at $4.00 per...

Windtree Therapeutics Inc (OTC: WINT) shares dipped 67.7 percent to $0.275 after the company disclosed top line results for its AEROSURF® phase 2b clinical trial for the treatment of respiratory distress syndrome in premature infants. The company announced that AEROSURF trial did not meet...

Rite Aid Corporation (NYSE: RAD) shares dropped 25.1 percent to $2.94. Rite Aid Corporation confirmed a finalized asset purchase agreement with rival Walgreens. Walgreens has attempted to acquire the entirety of Rite Aid since 2015, but instead Rite Aid will now sell 2,186 of its stores,...

Meridian Waste Solutions Inc (NASDAQ: MRDN) shares tumbled 30.9 percent to $1.66. Meridian Waste Solutions reported the pricing of its public offering. DryShips Inc. (NASDAQ: DRYS) shares dipped 19.8 percent to $2.05 after surging 9.21 percent on Tuesday. DryShips reported successful...

Ra Pharmaceuticals Inc (NASDAQ: RARX) shares dipped 22 percent to $17.30 after the company issued updates on Phase 2 trial of RA101495. Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 20.6 percent to $3.02 after the company reported results from Phase II study of TV-45070 in patients...

Neothetics Inc (NASDAQ: NEOT) shares dropped 69.6 percent to $0.709. Neothetics disclosed that LIPO-202 did not show any improvement on efficacy measurements. Matinas BioPharma Holdings Inc (NYSE: MTNB) shares declined 18.1 percent to $2.27. Matinas BioPharma reported that Phase 2 clinical...